DEXYCU

Generic: DEXAMETHASONE

Manufacturer: Eyepoint Pharmaceuticals Us, Inc

Corticosteroid [EPC]Thalidomide Analog [EPC]Proteasome Inhibitor [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Alkylating Drug [EPC]
282,319
Total Reports
126,088
Serious Reports
46,131
Death Reports
30
Reported Reactions
Death Report Ratio: High (16.34%)

Patient Demographics

Male
128,302
Female
120,926

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for DEXYCU.

# Reaction Reports % of Total
1 OFF LABEL USE 21,295
7.6%
2 FATIGUE 16,484
5.9%
3 DIARRHOEA 16,481
5.9%
4 PLASMA CELL MYELOMA 13,761
4.9%
5 NAUSEA 13,425
4.8%
6 PNEUMONIA 13,272
4.8%
7 DEATH 12,859
4.6%
8 DRUG INEFFECTIVE 12,338
4.4%
9 NEUTROPENIA 11,212
4.0%
10 PYREXIA 10,568
3.8%
11 THROMBOCYTOPENIA 10,241
3.7%
12 DYSPNOEA 9,869
3.5%
13 ANAEMIA 8,764
3.1%
14 FEBRILE NEUTROPENIA 8,690
3.1%
15 ASTHENIA 8,481
3.0%
16 VOMITING 8,460
3.0%
17 NEUROPATHY PERIPHERAL 8,243
3.0%
18 RASH 7,938
2.8%
19 DISEASE PROGRESSION 7,261
2.6%
20 CONSTIPATION 6,701
2.4%
21 SEPSIS 5,968
2.1%
22 DECREASED APPETITE 5,868
2.1%
23 PLATELET COUNT DECREASED 5,739
2.1%
24 HEADACHE 5,490
2.0%
25 DIZZINESS 5,347
1.9%
26 PAIN 5,319
1.9%
27 INFECTION 5,112
1.8%
28 HYPOTENSION 4,780
1.7%
29 MALAISE 4,660
1.7%
30 ACUTE KIDNEY INJURY 4,627
1.7%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.